S
Sandman
Good morning all!
I think I'll probably roll the bones, give him his maintenance chemo in 3 weeks without checking a neutrophil count even though it's lousy medicine and address the issue in 9 weeks when he's next due. It would probably be ok, since his neutrophils were only low during induction therapy, vet relations will be risky while he's on the protocol and his blood sugars go phase 2 booster in the ionosphere at the vets office every time. It would set him back. I hate doing that, but it is what it is.
he asked me why I didn't have Gracie on prozinc or compounded PZI.

Just wanted to remind our veterans and make it clear to new members that while this study was published in 2009, the study actually took place earlier. Without taking a whole lot of time to find the original date, I believe it was in the early 2000s, like 2005 or 2006. I only mention it because the study was done with PZI not Prozinc. PZI is no longer available and hasn't been for a few years now. Prozinc is a new and different insulin so we can't use the study cited above when comparing Lantus to the newer Prozinc insulin.There's a paper I found when I was tooling around on pubmed yesterday or today comparing remission rates for newly diagnosed diabetic felines by type of insulin. It's not directly applicable to my case, but let me look.
Here is the short & sweet answer to that internist. Glargine (lantus) cats got better. The others didn't.
Send to:
J Feline Med Surg. 2009 Aug;11(8):683-91. doi: 10.1016/j.jfms.2009.05.016. Epub 2009 Jun 18.
Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
Marshall RD1, Rand JS, Morton JM.
Author information
Abstract
Glycaemic control and remission probabilities were compared in 24 newly diagnosed diabetic cats treated twice daily with either glargine, protamine zinc (PZI) or lente insulin and fed a low carbohydrate diet. After day 17, the probability of remission was substantially higher for cats with lower mean 12h blood glucose concentrations on day 17, irrespective of insulin type. Glargine-treated cats had lower mean 12h blood glucose concentrations on day 17 than PZI- or lente-treated cats, and all eight glargine-treated cats achieved remission compared to three PZI- and two lente-treated cats. The probability of remission was greater for cats treated with glargine than cats treated with PZI or lente insulin. In newly diagnosed diabetic cats, twice daily treatment with glargine provides better glycaemic control and higher probability of remission compared to twice daily treatment with PZI or lente insulin. Good glycaemic control soon after diagnosis is associated with increased probability of remission and should be the goal of insulin therapy.
Yep. The insulin used in that study was PZI... the bovine insulin you're referring to.But wasn't PZI a bovine insulin as opposed to the prozinc which is human recombinant? At least theoretically that one was a much better match for feline insulin.
I'm with Julie.Regarding your suggestion... I really hate not being straightforward, or even worse lying. It's not my nature.